ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
19/04/2021 07:30
ERYTECH Announces Completion of First Cohort in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
07/04/2021 22:30
ERYTECH to Participate in Upcoming Virtual Investor Conferences in April
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
09/03/2021 22:30
ERYTECH Announces Filing of 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
08/03/2021 22:30
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
04/03/2021 22:30
ERYTECH to Host Fourth Quarter and Full Year 2020 Conference Call and Business Update
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
24/02/2021 22:30
ERYTECH to Participate in Upcoming Virtual Investor Conferences in March
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
10/02/2021 22:30
ERYTECH to Present at the 2021 BIO CEO & Investor Conference
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
04/02/2021 19:00
Monthly information related to total number of voting rights and shares composing the share capital – January 31, 2021
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
25/01/2021 22:30
ERYTECH Highlights 2021 Milestones and Provides Update on Cash Position
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
ERYTECH PHARMA
(EPA:ERYP)
14/01/2021 22:30
ERYTECH Announces First Patient Enrolled in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
Lire la news
Voir tous les communiqués de ERYTECH PHARMA
1
2
3
4
5
6
7
8
9
10
»